Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

Cosmo Pharmaceuticals' new drug, clascoterone, shows encouraging phase 3 results in treating male baldness, potentially revolutionising hair loss treatments.

An acne drug, clascoterone, has demonstrated remarkable results in treating male pattern baldness. In two large Phase III trials involving 1,500 men, participants using the topical solution ...

In a trial, clascoterone showed a whopping 539 percent relative improvement in hair count compared to the placebo.

Italian pharmaceutical company Cosmo Pharmaceuticals announced that its recently developed new male-pattern hair loss drug has shown significant results in Phase 3 clinical trials. The existing ...